11th Dec 2013 15:31
RNS Number : 3147V
GlaxoSmithKline PLC
11 December 2013
Board Committee change
GlaxoSmithKline plc announces that Lynn Elsenhans, a Non-Executive Director, has been appointed as a member of the Audit & Risk Committee with effect from 1 January 2014.
Sonja Arsenić
Corporate Secretariat
11 December 2013
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Glaxosmithkline